Candriam S.C.A.Candriam S.C.A.

Institutional investor · Portfolio as of Q2 2022

SEC EDGAR SourceSEC Filings

Top Holdings775 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2.4M$621.8M5.1%$158.98+59.10%
14 qtrssince 2019-Q1
Decreased
0

APPLE INC

3.2M$435.9M3.6%$108.79+23.09%
14 qtrssince 2019-Q1
Increased
61

ALPHABET INC-CL A

177,707$387.3M3.2%$67.83+63.43%
14 qtrssince 2019-Q1
Decreased
0

MERCK & CO. INC.

3.5M$317.4M2.6%$67.03+24.12%
14 qtrssince 2019-Q1
Decreased
0

AMGEN INC

935,915$227.7M1.9%$174.75+24.90%
14 qtrssince 2019-Q1
Increased
48

DANAHER CORP

888,842$225.3M1.9%$172.10+28.06%
14 qtrssince 2019-Q1
Increased
51

REGENERON PHARMACEUTICALS

372,793$220.4M1.8%$475.72+24.93%
14 qtrssince 2019-Q1
Increased
49

THERMO FISHER SCIENTIFIC INC

404,266$219.6M1.8%$400.24+32.57%
14 qtrssince 2019-Q1
Increased
51

PROCTER & GAMBLE CO/THE

1.4M$202.8M1.7%$111.70+15.17%
14 qtrssince 2019-Q1
Increased
58

UNITEDHEALTH GROUP INC

389,456$200M1.6%$324.84+49.36%
14 qtrssince 2019-Q1
Increased
53

ELI LILLY & CO

480,709$155.9M1.3%$233.78+33.97%
14 qtrssince 2019-Q1
Decreased
0
SGENSGENDelisted

SEAGEN INC

778,045$137.7M1.1%
7 qtrssince 2020-Q4
Decreased
0

VERTEX PHARMACEUTICALS INC

467,883$131.8M1.1%$200.81+39.61%
14 qtrssince 2019-Q1
Decreased
0

GILEAD SCIENCES INC

2M$125.5M1.0%$50.83+8.48%
14 qtrssince 2019-Q1
Increased
55

VISA INC-CLASS A SHARES

585,595$115.3M0.9%$177.38+7.44%
14 qtrssince 2019-Q1
Increased
48

JOHNSON & JOHNSON

641,771$113.9M0.9%$130.74+21.96%
14 qtrssince 2019-Q1
Decreased
0

AMAZON.COM INC

960,320$102M0.8%$108.94-0.02%
14 qtrssince 2019-Q1
Increased
68

ADOBE INC

277,923$101.7M0.8%$431.38-15.14%
14 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL C

46,193$101M0.8%$83.69+33.13%
14 qtrssince 2019-Q1
Decreased
0

NVIDIA CORP

646,914$98.1M0.8%$17.08-9.14%
14 qtrssince 2019-Q1
Increased
44
$12.1B
AUM
775
Positions
Q2 2022
Filing
Rating · 2.5
Quarterly Portfolio Change
-5%Q1'21$12B+22%Q2'21$14.6B+1%Q3'21$14.7B+7%Q4'21$15.7B-6%Q1'22$14.7B-17%Q2'22$12.1B
Activity profile
$ moved · Q2'22
New5%Increased31%Decreased59%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.5 years
<1Q6%1-4Q7%1-2Y12%2Y+75%

Candriam S.C.A. manages $12.1B across 775 positions as of Q2 2022. Top holdings: MSFT (5.1%), AAPL (3.6%), GOOGL (3.2%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2.5/5.0.

Q2 2022 Summary

Active quarter - 60 new positions, 93 exits, 326 increased. Top move: AMZN (INCREASED, conviction 68). Portfolio: $12.1B across 775 positions.

Top holdings by portfolio weight

Total AUM$12B
MSFT5.12%
AAPL3.59%
GOOGL3.19%
MRK2.61%
AMGN1.88%
DHR1.86%
REGN1.81%
TMO1.81%
PG1.67%
UNH1.65%
Other1.28%

Portfolio allocation by GICS sector

Sectors11
Healthcare31.12%
Technology23.42%
Financial Services8.32%
Consumer Cyclical6.59%
Industrials6.51%
Communication Services6.50%
Unknown5.90%
Consumer Defensive5.29%
Basic Materials2.07%
Real Estate1.95%
Other2.33%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record80
Conviction42
Concentration49
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AEMAEMAGNICO EAGLE MINES LTD
Q3 2024 Q2 2026+367,189 shares+$57.7M
8Q
AMZNAMZNAMAZON.COM INC
Q3 2024 Q2 2026+1.1M shares+$328M
8Q
CCCITIGROUP INC
Q3 2024 Q2 2026+275,890 shares+$52.2M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used